Etrolizumab Antibody
Etrolizumab is a humanized monoclonal antibody targeting the β7 integrin, designed to inhibit lymphocyte trafficking to the gut. It is a research tool for studying inflammatory bowel disease (IBD), with applications in both in vitro binding assays and in vivo models of intestinal inflammation.
Product Specifications
Product Name Alternative
Integrin, RG 7413, RG7413, rhuMAb Beta7, PRO145223, PRO 145223
Target
Integrin
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Signal Transduction
Concentration
5.46 mg/mL
Purity
96.60% (May vary between batches)
Molecular Weight
144.1 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bsm-52770R-BF405-TR 20 µL
DUSP1 Recombinant Antibody, AbBy Fluor™ 405 Conjugated
Sign In for Pricing
View Details 
RDR-ACE-Ra-96Tests 96 Tests
Rat Angiotensin I Converting Enzyme (ACE) ELISA Kit
Sign In for Pricing
View Details ![Mouse Monoclonal DRAP1 Antibody (PCRP-DRAP1-1A8) [DyLight 488]](https://cdn.genprice.uk/genprice/uk/genprice3.webp)
NBP3-24153G 0.1 mL
Mouse Monoclonal DRAP1 Antibody (PCRP-DRAP1-1A8) [DyLight 488]
Sign In for Pricing
View Details MBS8113268-02 5x 0.1 mL
Anti-CD166/ALCAM Antibody, Rabbit Polyclonal
Sign In for Pricing
View Details